التفاصيل البيبلوغرافية
| العنوان: |
Atopic dermatitis may not confer clinically meaningful risk of inflammatory bowel disease or renal malignancy. |
| المؤلفون: |
Gantz HY; Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina. Electronic address: gantzhannah@gmail.com., Greenzaid JD; Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina., Feldman SR; Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina; Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, North Carolina; Department of Social Sciences & Health Policy, Wake Forest University School of Medicine, Winston-Salem, North Carolina; Department of Dermatology, University of Southern Denmark, Odense, Denmark. |
| المصدر: |
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Sep; Vol. 91 (3), pp. 586-588. Date of Electronic Publication: 2024 Jun 04. |
| نوع المنشور: |
Letter; Journal Article |
| اللغة: |
English |
| بيانات الدورية: |
Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE |
| أسماء مطبوعة: |
Original Publication: St. Louis, Mo., Mosby |
| مواضيع طبية MeSH: |
Dermatitis, Atopic*/epidemiology , Kidney Neoplasms*/epidemiology , Inflammatory Bowel Diseases*/epidemiology , Inflammatory Bowel Diseases*/complications, Humans ; Male ; Female ; Middle Aged ; Adult ; Risk Assessment ; Risk Factors ; Aged |
| مستخلص: |
Competing Interests: Conflicts of interest Dr Feldman has received research, speaking and/or consulting support from Eli Lilly and Company, GlaxoSmithKline/Stiefel, AbbVie, Janssen, Alovtech, vTv Therapeutics, Bristol-Myers Squibb, Samsung, Pfizer, Boehringer Ingelheim, Amgen, Dermavant, Arcutis, Novartis, Novan, UCB, Helsinn, Sun Pharma, Almirall, Galderma, Leo Pharma, Mylan, Celgene, Ortho Dermatology, Menlo, Merck & Co, Qurient, Forte, Arena, Biocon, Accordant, Argenx, Sanofi, Regeneron, the National Biological Corporation, Caremark, Teladoc, BMS, Ono, Micreos, Eurofins, Informa, UpToDate and the National Psoriasis Foundation. He is founder and part owner of Causa Research and holds stock in Sensal Health. Authors Gantz and Greenzaid have no conflicts of interest to declare. |
| فهرسة مساهمة: |
Keywords: atopic dermatitis; clinical meaning; general dermatology; inflammatory bowel disease; relative risk; renal malignancy; statistical review |
| تواريخ الأحداث: |
Date Created: 20240606 Date Completed: 20240822 Latest Revision: 20240822 |
| رمز التحديث: |
20240823 |
| DOI: |
10.1016/j.jaad.2024.05.072 |
| PMID: |
38844010 |
| قاعدة البيانات: |
MEDLINE |
Full Text via ClinicalKey 
Full Text Finder